CXCL10 and inflammatory bowel disease: Cxcl10 expression is reported as being localised mainly to epithelial cells in the intestinal mucosa, with increased levels seen in IBD tissues (85), where mucosal levels of pro-inflammatory TNF are also notably high (27).